% !TeX root = RJwrapper.tex
\title{RNA-Seq reveals differentially expressed genes in post-mortem autism
spectrum disorder}
\author{by Debra T. Linfield, Raoul R. Wadhwa}

\maketitle

\abstract{%
\citet{orig-paper} used gene set enrichment analysis to show significant
differential expression of genes in the histamine signaling pathway
between matched quadruples of cognitively typical subjects (\(n=39\))
and patients diagnosed with autism spectrum disorder (\(n=13\)) using
postmortem biopsies of the dorsolateral prefrontal cortex in the human
brain. Here, we replicate their initial differential gene expression
analysis between the two groups, and conduct a biological analysis of
the significantly differentially expressed SCARNA genes responsible for
development and maintenance of cells in the central nervous system that
were not explored by the original paper. To emphasize reproducibility,
this report was generated with Rmarkdown that regenerates all figures
within code chunks each time the document is knitted, and appendices at
the end supply all necessary components for exact recreation of this
report from the original paper's data stored in a publicly accessible
archive.

\noindent \textbf{Word count}: 1958 (excluding appendices, captions)
}

\section{Introduction}\label{introduction}

Autism spectrum disorder (ASD) is a set of developmental conditions with
a wide variety of symptoms, generally related to social behaviors
\citep{brentani2013}. Studying ASD is complicated by the variety of its
clinical manifestations and the existence of many monogenic, Mendelian
disorders that cause the symptom of autistic behavior in patients
\citep{ivanov2015}. Specifically, observation of potentially autistic
behavior in a patient is insufficient for diagnosis of ASD. This is
especially true for pediatric patients, many of whom are not
conclusively diagnosed with ASD until they are 5 or 6 years of age
\citep{ellerbeck2015}.

Histamine is a compound released by cells as part of the immune
response, with increased levels being observed in cases of
neuroinflammation \citep{jutel2005}. \citet{fernandez2012} showed that
Tourette syndrome (TS), which is the most commonly observed comorbidity
in patients diagnosed with ASD, is related to dysregulation of histamine
signaling pathways. Moreover, the pathogenetic state of TS has been
shown to have significant overlap with ASD \citep{clarke2012}.
Additionally, niaprazine - an antihistaminergic drug - has been used
with some success for the treatment of ASD \citep{rossi1999}. Given the
past medical use of an antihistaminergic for ASD treatment and due to
the known role of the histamine signaling pathway in the pathobiology of
TS, the histamine signaling pathway is a natural target for RNA-Seq
studies \citep{orig-paper}.

This report replicates the differential gene expression analysis
conducted by \citet{orig-paper} with relation to the histamine signaling
pathway. However, rather than replicating the already completed gene set
enrichment analysis of this pathway, we explore the set of
differentially expressed genes not further analyzed by the original
paper.

\section{Materials and Methods}\label{materials-and-methods}

\subsection{Replication analysis
methods}\label{replication-analysis-methods}

After download of sample data from SRA and subsequent conversion into
fastq files using the \texttt{fastq-dump} command line tool, skewer
\citep{skewer}, HiSat2 \citep{hisat}, SAMtools \citep{samtools}, and
featureCounts \citep{featurecounts} were used for trimming, alignment,
formatting, and counting the RNA-Seq output, respectively (see
Appendices A and B for details). Due to technical restrictions
associated with data processing, all 39 control samples could not be
used in this study; with permission of the teaching assistant, a subset
of 13 controls was analyzed. The conducted analysis did include all 13
experimental samples from the original study. The R programming language
\citep{R} was used for further data processing. Specifically, the
tidyverse package \citep{tidyverse} was used for data visualization,
DESeq2 \citep{deseq} was used for differential gene expression analysis,
and knitr \citep{knitr3,knitr2,knitr1} was used for typesetting in
conjunction with the xtable \citep{xtable}, gplots \citep{gplots},
RColorBrewer \citep{rcolorbrewer}, pheatmap \citep{pheatmap}, vsn
\citep{vsn}, and formatR \citep{formatr} packages. For the purpose of
reproducibility and in support of the Open Science movement, this report
was written in Rmarkdown with all plots produced programmatically within
code chunks and reconstructed each time the document was knitted. The
Rmarkdown file and all associated dependencies can be found on
\href{https://github.com/rrrlw/RNASeq-ASD}{GitHub} (see Appendix A for
details).

\subsection{Relevant methods from original
study}\label{relevant-methods-from-original-study}

Post-mortem brain tissue samples from 52 subjects were collected, 39 of
which were from non-psychiatric controls subjects, while 13 were from
patients diagnosed with ASD. The post-mortem homogenate grey matter
samples were collected from Brodmann area 46 and 9. RNA was extracted
from the tissue using the RNeasy kit. RNA-Seq was then performed on the
extracted RNA using the TruSeq Stranded Total RNA Library Preparation
kit in conjunction with Illumina Ribo-Zero Gold ribosomal RNA depletion.
All except 5 mismatched control subjects were matched (3:1
control:experimental ratio) to a subject in the experimental group of
the same gender, ethnicity, and age (within 6 years) to control for
genetic variation as a result of these factors. Differential expression
analysis was conducted on log-normalized gene expression values after
exclusion of genes with low expression values.

\citet{orig-paper} also performed a replication analysis of the results
found by \citet{replicate-paper}; this replication analysis is not
repeated within this report due to lack of information necessary for
complete reproducibility, specifically, the lack of sample labeling for
identification of the overlapping samples between the two studies (see
\citet{orig-paper} for details).

\section{Results and Discussion}\label{results-and-discussion}

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/disperseplot-1} \caption{\label{fig:displot}\textbf{Gene dispersion plot for quality control.} Note that raw dispersions are not plotted. Instead, corrected dispersions are graphed as a scatterplot, and dispersion is then fitted as a function of normalized counts by the black line. Log-log axes are used for clarity of visualization.}\label{fig:disperseplot}
\end{figure}
\end{Schunk}

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/vstplot-1} \caption{\label{fig:vst}\textbf{Standard deviation of expression data transformed with the variance stabilizing transformation.} The constant variation (measured by standard deviation) across the range of genes ranked by mean expression satisfies the assumptions required of RNA-Seq for analysis by the DESeq2 pipeline.}\label{fig:vstplot}
\end{figure}
\end{Schunk}

A gene dispersion plot (Figure \ref{fig:displot}) is generated for
quality control (QC). As expected, higher dispersion is observed for
genes with lower normalized counts. The dispersion decreases and quickly
flattens for increasing values of normalized counts. This pattern is
consistent with expected results as stated by \citet{deseq}.
Additionally, the variation plot of genes ranked by mean expression
(Figure \ref{fig:vst}) shows a constant standard deviation across the
range of all genes ranked by mean expression, further satisfying the
requirements of DESeq2 analysis checked by QC \citep{deseq}. A clear
benefit of Figure \ref{fig:vst} over Figure \ref{fig:displot} is the use
of hexagon binning to convey the density of points in the plot.

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/maplot-1} \caption{\label{fig:maplot}\textbf{MA plot for QC.} Points colored black represent genes with similar expression across groups; points colored red represent differentially expressed genes. As expected, most genes lie near $y=0$, indicating that only a minority of genes are differentially expressed between the control and experimental groups. The vertical axis is log-transformed for clarity of visualization.}\label{fig:maplot}
\end{figure}
\end{Schunk}

An MA plot was generated for QC (Figure \ref{fig:maplot}). Genes that
are not differentially expressed (black points) between groups have a
fold change close to unity and a log fold change close to zero, whereas
differentially expressed genes (red points) are located farther from the
horizontal axis, as expected. Thus, the MA plot shows that normalized
count data is comparable between the sample groups since normalization
was able to correct for artifacts that caused meaningless differences in
counts between groups. Given that log fold change shrinkage methods were
not applied to the MA plot, the visualized data does not raise concerns
with regard to QC as stated by \citet{deseq}.

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/pcaplot-1} \caption{\label{fig:pcaplot}\textbf{PCA plot of samples graphed by first two PCs.} Control ($n=13$) and experimental ($n=13$) samples appear interspersed. A single control sample appears to be separated from the rest. See corresponding text for further discussion.}\label{fig:pcaplot}
\end{figure}
\end{Schunk}

Principal component analysis (PCA) was conducted for QC (Figure
\ref{fig:pcaplot}), and each sample was plotted based on the first two
principal components (PCs). It is of note that the control and
experimental samples are not trivially clustered based on only the first
two PCs. This could be indicative of either non-genetic mechanisms being
responsible for ASD diagnoses or of relatively small genetic
modifications having large epigenetic effects. In the former case, a lack
of genetic changes in the experimental group relative to the control
samples would explain interspersion of samples from both groups within
the PCA plot. In the latter case, small genetic changes would not create
a great deal of variance in the high-dimensional vectors representing
the transcriptome. As such, these minor modifications would not be
incorporated in the first two PCs, and would thus not prevent
interspersion of samples from both groups in the 2-dimensional PCA plot.
It is also of note that one sample appears separated from the other
twenty-five. It is possible that this separation is an artifact of the
study method, with the postmortem biopsy causing alteration of the
observed transcriptome. However, \citet{orig-paper} stated that not all
52 samples were able to be matched properly in the matched quadruplet
design. Given the robust method of biopsy and RNA extraction used, it is
more likely that this sample was simply one of the ones that was not
quadruplet matched. It is also possible that since the first two PCs
capture less than half (49\%) of the variation within the samples' gene
expression, this is insufficient to add proper separation between the
control and experimental samples, thus causing a slightly higher
separation for a single sample to stand out by chance.

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/sampleheat-1} \caption{\label{fig:sampleheat}\textbf{Heatmap of sample distance matrix.} Each square is colored based on the distance between the samples labeling the row and column that intersect to form the square; a darker color indicates less distance (higher similarity) between samples. Rows are not explicitly labeled by sample, but labeling can be inferred using column labels and the main diagonal filled with squares of distance zero. Clustering visualized by dendrograms on the heatmap confirm the interspersion of samples between groups illustrated in the PCA plot (Figure \ref{fig:pcaplot}).}\label{fig:sampleheat}
\end{figure}
\end{Schunk}

A heatmap based on distances between samples was constructed for further
QC (Figure \ref{fig:sampleheat}). Dendrogram clustering of the samples
based on Euclidean distance between the vectors representing gene
expression of the corresponding samples confirmed the results from the
PCA plot (Figure \ref{fig:pcaplot}): clustering does not split the
samples into the control and experimental groups; rather, there is
interspersion of samples from both groups in each cluster. The
dendrogram and coupled labeling on the heatmap also indicate that the
control sample separated from the other samples in the PCA plot (Figure
\ref{fig:pcaplot}) is likely ``C21'' (SRR5938421).

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/volcanoplot-1} \caption{\label{fig:volplot}\textbf{Volcano plot to characterize the number of genes with significantly altered gene expression.} Points in black represent genes without significantly altered expression level between groups, and points in red represent genes expressed differentially in patients diagnosed with ASD ($\alpha=0.01$).}\label{fig:volcanoplot}
\end{figure}
\end{Schunk}

A volcano plot was generated to determine if any genes were
differentially expressed between the experimental and control groups
(Figure \ref{fig:volplot}). Points in red are genes that are
differentially expressed. While it can be seen that there is
differential expression in a small percentage of the genes, the identity
of differentially expressed genes cannot be discerned from this graph.

\begin{table}[ht]
\centering
\begin{tabular}{lrr}
  \hline
Gene Name & Log2 Fold Change & Adjusted p-value \\ 
  \hline
HDC & -0.39 & 0.82 \\ 
  HNMT & 0.10 & 0.82 \\ 
  HRH1 & 0.15 & 0.73 \\ 
  HRH2 & -0.30 & 0.66 \\ 
  HRH3 & 0.03 & 0.98 \\ 
  HRH4 & -0.08 & 0.97 \\ 
   \hline
\end{tabular}
\caption{\textbf{Differential expression of genes in the histamine signaling pathway.} Replication of the study by Wright et al. (2017) confirms that individual genes in the histamine signaling pathway are not significantly differentially expressed in patients diagnosed with ASD.} 
\label{tbl:histgenes}
\end{table}

Table \ref{tbl:histgenes} validates our replication of the study by
\citet{orig-paper}, showing that our calculated adjusted p-values are
similar to those of the original study. These values indicate that
without gene set enrichment analysis to highlight the histamine
signaling pathway, no single gene in the pathway is significantly
differentially expressed. Thus, analysis by \citet{orig-paper}
demonstrating the significant change in expression of the histamine
signaling pathway in patients diagnosed with ASD indicates that altering
expression of a single member of the histamine signaling pathway is
likely insufficient to explain the pathogenetic mechanism underlying the
symptoms of ASD. This is expected for a disorder as complex as ASD.

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/countplot-1} \caption{\label{fig:countplot}\textbf{Normalized counts of genes in histamine signaling pathway compared by group and faceted by gene identity.} Examination of the normalized counts between conditions confirms the lack of differential gene expression between groups. This likely indicates that lack of significance reflects a lack of biological significance, rather than a lack of statistical significance due to parameters such as sample size. The vertical axes is log-scaled for clarity of visualization. Error bars represent standard deviation around mean.}\label{fig:countplot}
\end{figure}
\end{Schunk}

Given that the individual genes in the histamine signaling pathway do
not appear to have altered expression levels between groups, but there
is good scientific justification to suspect the expression levels should
be altered, we plot the normalized counts of the two groups, faceted for
each of the six genes (Figure \ref{fig:countplot}). The bar plot reveals
no biological difference in expression levels between groups for genes
that were part of the histamine signaling pathway. This validates the
idea that gene set enrichment of the histamine signaling pathway is
required to observe differential expression of genes in the pathway
\citep{orig-paper}.

\begin{Schunk}
\begin{figure}
\includegraphics{FinalPaper_files/figure-latex/countheat-1} \caption{\label{fig:countheat}\textbf{Heatmap of differentially expressed genes between cognitively typical subjects (left half, prefix 'C') and patients diagnosed with ASD (right half, prefix 'E').} Heterogeneous gene expression within groups (e.g. expression of RNY and SNOR genes within experimental group) likely indicates expression dependent on particular clinical manifestations of ASD, reducing the power of this RNA-Seq to detect altered gene expression between groups. However, the SCARNA genes (SCARNA10 and SCARNA23) appear to have relatively homogeneous expression within groups and with significantly reduced expression in the experimental group (p << 0.01).}\label{fig:countheat}
\end{figure}
\end{Schunk}

\begin{table}[ht]
\centering
\begin{tabular}{lrr}
  \hline
Gene Name & Log2 Fold Change & Adjusted p-value \\ 
  \hline
SNORA74B & -1.98 & 0.00 \\ 
  SNORA74A & -2.10 & 0.00 \\ 
  SNORD94 & -1.93 & 0.00 \\ 
  RNU2-2P & -2.51 & 0.00 \\ 
  RNU5A-1 & -3.43 & 0.00 \\ 
  RNU5B-1 & -3.28 & 0.00 \\ 
   \hline
\end{tabular}
\caption{\textbf{Most significantly differentially expressed genes between cognitively typical subjects and subjects diagnosed with autism spectrum disorder (ASD).} Summary data for the six genes with the most significantly altered expression between groups is shown, with a complete table given in Appendix C. A significance threshold of 0.01 post-correction for false discovery rate was used to identify differentially expressed genes.} 
\label{tbl:dge}
\end{table}

Table \ref{tbl:dge} lists the genes with the most significantly altered
expression between groups (see Appendix C for complete list), and Figure
\ref{fig:countheat} uses a heatmap to visualize normalized gene
expression for each sample. Figure \ref{fig:countheat} reveals reliably
differential expression of SCARNA10 and SCARNA23 between the control and
experimental groups, with low variation within groups and significant
variation between groups. The SCARNA genes are cajal body-specific
molecules found primarily in metabolically active cells, particularly
neurons \citep{cajal}. Given their importance in the development and
maintenance of the central nervous system, differential expression of
SCARNA genes could plausibly have a relationship to the onset of ASD.
Due to the relatively low variation of SCARNA genes within the
experimental group, altered expression of these genes could be a common
transcriptomic feature observed across a variety of clinical
manifestations of ASD, and could elucidate important pathways involved
in the pathogenesis of this complex disorder.

\section{Conclusions}\label{conclusions}

We found similar results to \citet{orig-paper}. The potential issues in
the quality control (QC) plots did not cause any unexpected results. The
SCARNA genes were significantly differentially expressed between groups
(Figure \ref{fig:countheat}), while there were no significant
differences in expression of histamine signaling genes between patients
diagnosed with ASD and cognitively typical subjects (Figure
\ref{fig:countplot}). Further elucidation of the genetic pathogenesis of
ASD would require dedicated wet-lab experiments to isolate causal
relationships between reduced expression of the SCARNA10 and SCARNA23
genes and the onset of ASD.

Sample selection was one of the primary strengths of the study conducted
by \citet{orig-paper}. First, the sample size of 52 is larger than most
RNA-Seq studies, and grants more power for identification of
differentially expressed genes. This gain in power is particularly
important when gene set enrichment analysis is conducted as it involves
a more in-depth look at a gene set picked \emph{a priori}. Additionally,
in the original study, the samples were cross-matched in a 3:1
control:experimental ratio by age at death, cause of death, and
ethnicity. This matched quadruplet design helped control for incidental
differential gene expression as a result of the aforementioned factors.
It should be noted that although the original datasets were provided
through the Sequence Read Archive (SRA), the analysis pipeline was not
easily found and the sample labels for cross-matching were not publicly
available. Given that only a subset of the control samples were used,
the matched quadruplet design could not be replicated. However, the
replicated differential expression values match relatively closely to
the values reported by \citet{orig-paper}.

One limitation of the study by \citet{orig-paper} was the selected
operationalization of autism spectrum disorder (ASD). Given that ASD is
a class of NDDs, blocking for a distinctive etiology of autism would
have garnered more meaningful results. Due to the wide variety of
manifestations of ASD, there is a loss of power in differential gene
expression analysis if each of the experimental samples differentially
expresses a unique gene pathway. This is particularly clear for one
matched quadruplet of samples (3 controls, 1 experimental) where the age
of death was less than 5 years old. Although some clinical
manifestations of ASD can be diagnosed at less than 18 months of age,
the absence of a clear test (e.g.~blood test) for ASD makes diagnosis
tricky for younger subjects. However, it may not be realistic to find 13
post-mortem brain biopsies from subjects exhibiting identical forms of
ASD, so this was a justifiable compromise made by \citet{orig-paper}.

\section{Acknowledgments}\label{acknowledgments}

We thank Dr.~GÃ¼rkan Bebek and Peter Wilkinson for assistance with this
project. This work made use of the High Performance Computing Resource
in the Core Facility for Advanced Research Computing at Case Western
Reserve University.

\pagebreak
\bibliography{RJreferences}

\pagebreak
\appendix
\section{Appendix A: Reproducible Scripts for Replicating Results}
\label{appen:hpc-code}

The Rmarkdown file knitted to generate this report can be found at
\url{https://github.com/rrrlw/RNASeq-ASD}. The code chunks in this
Rmarkdown file contain all necessary elements to recreate all of the
plots; note that the working directory in the GitHub repository also
contains the counts file (output from subread's featureCounts) that is
read in and processed by the Rmarkdown. However, since R was not used
for primary processing of the RNA-Seq data, the next paragraph and
associated code chunk include details and code for reproducing that
portion of the pipeline.

The bash script below reproduces the processing steps of the RNA-Seq
analysis pipeline prior to input of counts into R and analysis by
DESeq2. The fastq-dump tool can be used to extract fastq files from the
files obtained from the SRA. See GEO page with ID GSE102741 for details
on which files on the SRA correspond to the work done by
\citet{orig-paper}. Note that the bash script completes processing for
all 52 samples used in the original study, not just the subset examined
in this paper. Also note that the below code assumes that three empty
directories named \texttt{readsTrimmed}, \texttt{alignments}, and
\texttt{counts} exist in the working directory; additionally, the
appropriate HiSat2 indexing file should be located in
\texttt{HiSatIndex/human} and the genome gtf for the counting step
should be a file named \texttt{genes.gtf} in the working directory.

\begin{Schunk}
\begin{Sinput}
##### TRIMMING (skewer) #####
module load skewer

# trim all samples
for i in {19..70}
do
    skewer --mode pe --threads 8 --mean-quality 30 --min 36 -q 30 --output
        readsTrimmed/S${i}.fastq --compress -y AGATCGGAAGAGC -x
        AGATCGGAAGAGC SRR59384${i}_1.fastq.gz SRR59384${i}_2.fastq.gz
done

##### ALIGNING (HiSat2) #####
module load hisat2
module add samtools

for i in {19..70}
do
    # SAM file creation
    hisat2 -p 12 -x HiSatIndex/human -1 readsTrimmed/S${i}.fastq-trimmed-pair1.fastq.gz
        -2 readsTrimmed/S${i}.fastq-trimmed-pair2.fastq.gz -S alignments/S${i}.sam
    
    # conversion from SAM to BAM
    samtools view -bS alignments/S${i}.sam | samtools sort -o alignments/S${i}.bam
    
    # BAM indexing
    samtools index alignments/S${i}.bam alignments/S${i}.bam.bai
    
    # flagstat to validate BAM file content
    samtools flagstat alignments/S${i}.bam > alignments/C${i}.flagstat
    
done

##### COUNTING (featureCounts) #####
module load subread

# count features in all BAM files
featureCounts -T 8 -s 0 -p -a genes.gtf -o counts/gene_id.counts alignments/*.bam
\end{Sinput}
\end{Schunk}

\pagebreak
\section{Appendix B: Version Numbers of Tools used for Analysis}

\begin{table}[ht]
\centering
\begin{tabular}{lll}
  \hline
Tool Name & Version & Reference \\ 
  \hline
Skewer & 0.2.2 & Jiang et al. (2014) \\ 
  HiSat2 & 2.1.0 & Kim et al. (2015) \\ 
  SAMtools & 1.8 & Li et al. (2009) \\ 
  featureCounts & 1.5.0-p2 & Liao et al. (2014) \\ 
  DESeq2 & 1.16.1 & Love et al. (2014) \\ 
  tidyverse & 1.2.1 & Wickham (2017) \\ 
  knitr & 1.20 & Xie (2018) \\ 
  RColorBrewer & 1.1-2 & Neuwirth (2014) \\ 
  gplots & 3.0.1 & Warnes et al. (2016) \\ 
  xtable & 1.8-2 & Dahl (2016) \\ 
  pheatmap & 1.0.8 & Kolde (2015) \\ 
  formatR & 1.5 & Xie (2017) \\ 
  vsn & 3.6 & Huber et al. (2002) \\ 
   \hline
\end{tabular}
\caption{For reproducibility, this table lists the version numbers of every tool or package used in this report. To find the appropriate software repository/archive for each tool, see the associated reference.} 
\label{tbl:tools}
\end{table}

\pagebreak
\section{Appendix C: Complete List of Differentially Expressed Genes}

\begin{table}[ht]
\centering
\begin{tabular}{lrrr}
  \hline
Gene Name & Log2 Fold Change & Standard Error (LFC) & Adjusted p-value \\ 
  \hline
RNU5B-1 & -3.28 & 0.32 & 0.00 \\ 
  RNU5A-1 & -3.43 & 0.35 & 0.00 \\ 
  RNU2-2P & -2.51 & 0.31 & 0.00 \\ 
  SNORD94 & -1.93 & 0.24 & 0.00 \\ 
  SNORA74A & -2.10 & 0.29 & 0.00 \\ 
  SNORA74B & -1.98 & 0.28 & 0.00 \\ 
  SNORA22 & -1.48 & 0.23 & 0.00 \\ 
  SNORA53 & -1.25 & 0.21 & 0.00 \\ 
  SNORA23 & -1.89 & 0.34 & 0.00 \\ 
  RNU6ATAC & -1.18 & 0.22 & 0.00 \\ 
  LOC102723926 & 0.58 & 0.11 & 0.00 \\ 
  CRLF3 & 0.33 & 0.07 & 0.00 \\ 
  RNY3 & -2.05 & 0.40 & 0.00 \\ 
  TOR1AIP2 & 0.22 & 0.04 & 0.00 \\ 
  RNY1 & -2.58 & 0.53 & 0.00 \\ 
  SNORD9 & -1.25 & 0.26 & 0.00 \\ 
  SNORD17 & -1.20 & 0.25 & 0.00 \\ 
  SNORA81 & -1.03 & 0.22 & 0.00 \\ 
  RP11-806K15.1 & 0.57 & 0.12 & 0.00 \\ 
  PDE5A & 0.42 & 0.09 & 0.00 \\ 
  RNU11 & -1.62 & 0.34 & 0.00 \\ 
  SCARNA10 & -1.06 & 0.23 & 0.00 \\ 
  E2F1 & -0.48 & 0.10 & 0.00 \\ 
  SYCP3 & 0.60 & 0.13 & 0.00 \\ 
  RNU105A & -1.14 & 0.25 & 0.01 \\ 
  C9orf84 & 0.72 & 0.16 & 0.01 \\ 
  CLDN10 & 0.55 & 0.12 & 0.01 \\ 
  SCARNA23 & -2.04 & 0.46 & 0.01 \\ 
  ERO1LB & 0.36 & 0.08 & 0.01 \\ 
  ZSCAN29 & -0.26 & 0.06 & 0.01 \\ 
  SNORA64 & -1.13 & 0.26 & 0.01 \\ 
  ADAT2 & 0.34 & 0.08 & 0.01 \\ 
  SNORA67 & -1.05 & 0.24 & 0.01 \\ 
   \hline
\end{tabular}
\caption{\textbf{Complete list of differentially expressed genes.} The complete list of differentially expressed genes for significance level 0.01; these genes exhibited a significantly altered expression level in patients diagnosed with ASD.} 
\label{tbl:alldeg}
\end{table}

\pagebreak
\section{Author Contact and Affiliations}

\address{%
Debra T. Linfield\\
Department of Systems Biology and Bioinformatics, Case Western Reserve
University, Cleveland, OH 44106, U.S.A.\\
\\
}
\href{mailto:debra.linfield@case.edu}{\nolinkurl{debra.linfield@case.edu}}

\address{%
Raoul R. Wadhwa\\
Department of Systems Biology and Bioinformatics, Case Western Reserve
University, Cleveland, OH 44016, U.S.A.\\
\\
}
\href{mailto:raoul.wadhwa@case.edu}{\nolinkurl{raoul.wadhwa@case.edu}}

